Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 8/20 | 0.50 |
| ▸ | CALCR | P30988 | 8/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.48 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.48 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 2/20 | 0.47 |
| ▸ | NPY4R | P50391 | 2/20 | 0.47 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437941 | 0.99 | RAMP3 (0.49) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL29437933 | 0.97 | RAMP3 (0.49) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL30495666 | 0.94 | NMUR2 (0.46) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL30009447 | 0.93 | NMUR2 (0.52) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL31344127 | 0.92 | NMUR2 (0.47) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL31416061 | 0.91 | RAMP3 (0.51) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL29453625 | 0.91 | RAMP3 (0.53) | RAMP3CALCRNMUR2NMUR1NPY2R | |
| SCHEMBL30973992 | 0.90 | RAMP3 (0.54) | RAMP3CALCRNMUR2NMUR1 | |
| SCHEMBL30509906 | 0.89 | OPRM1 (0.52) | RAMP3CALCROPRM1OPRK1NMUR2 | |
| SCHEMBL30799320 | 0.89 | RAMP3 (0.50) | RAMP3CALCROPRM1OPRK1NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321241-A1 | CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME | BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) | 2023-10-12 | — | — | US | claimed |
| CN-116261450-A | Cancer peptide vaccine and preparation method thereof | 亮径生物疗法有限公司 | 2023-06-13 | — | — | CN | claimed |
| WO-2023013755-A1 | CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2023-02-09 | — | — | WO | claimed |
| WO-2022025093-A1 | CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2022-02-03 | — | — | WO | claimed |
| US-20230321241-A1 | CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME | BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230321241-A1 | CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME | BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| CN-116261450-A | Cancer peptide vaccine and preparation method thereof | 亮径生物疗法有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-116261450-A | Cancer peptide vaccine and preparation method thereof | 亮径生物疗法有限公司 | 2023-06-13 | — | — | CN | disclosed |
| WO-2023013755-A1 | CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2023-02-09 | — | — | WO | disclosed |
| WO-2022025093-A1 | CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022025093-A1 | CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME | ブライトパス・バイオ株式会社 | 2022-02-03 | — | — | WO | disclosed |